What are the side effects of immunotherapy for Endometrial Cancer

Side Effects of Immunotherapy for Endometrial Cancer

Immunotherapy has become an important treatment option for endometrial cancer, particularly for advanced or recurrent cases. Understanding potential side effects is crucial for informed decision-making with your care team.

Common Immunotherapy Drugs Used in Endometrial Cancer

According to NCCN Guidelines, the immunotherapy drugs most commonly used for endometrial cancer include:

• Pembrolizumab (Keytruda)
• Dostarlimab (Jemperli)
• Durvalumab (Imfinzi)
• Nivolumab (Opdivo)

These are checkpoint inhibitors—drugs that work by "releasing the brakes" on your immune system so it can better recognize and attack cancer cells.

How Immunotherapy Side Effects Differ

Unlike traditional chemotherapy, which damages cells directly, immunotherapy side effects occur because your immune system becomes more active. This can cause immune-related adverse events (irAEs)—inflammation in various parts of your body.

Common Side Effects

Mild to Moderate (Most Frequent):

• Fatigue and weakness
• Fever
• Chills
• Headache
• Muscle or joint aches
• Rash or skin reactions
• Nausea and loss of appetite
• Diarrhea or constipation

More Serious (Less Common but Important):

• Lung inflammation (pneumonitis) – difficulty breathing, persistent cough
• Liver inflammation (hepatitis) – yellowing of skin/eyes, dark urine, abdominal pain
• Thyroid problems – fatigue, weight changes, temperature sensitivity
• Kidney inflammation (nephritis) – changes in urination, swelling
• Colon inflammation (colitis) – severe diarrhea, abdominal pain, blood in stool
• Heart inflammation (myocarditis) – chest pain, shortness of breath, irregular heartbeat
• Nervous system effects – numbness, weakness, vision changes
• Hormone gland inflammation (pituitary/adrenal) – severe fatigue, dizziness, low blood pressure

Important Context from Clinical Trials

According to NCCN Guidelines, when pembrolizumab was combined with chemotherapy in the KEYNOTE-B21 trial for high-risk endometrial cancer, the side effect profile was manageable in most patients. Similarly, the RUBY trial (dostarlimab plus chemotherapy) and DUO-E trial (durvalumab plus chemotherapy) showed that while side effects occurred, they were generally treatable.

Managing Side Effects

Your oncology team will:

• Monitor you closely with blood tests and physical exams
• Treat side effects promptly (often with steroids for immune-related inflammation)
• Adjust or pause treatment if needed
• Provide supportive medications

You should report immediately:

• Severe shortness of breath
• Chest pain or irregular heartbeat
• Severe diarrhea or abdominal pain
• Vision changes
• Severe headache or confusion
• Any new or worsening symptoms

Questions to Ask Your Oncologist

1. Which specific immunotherapy drug are you recommending for me, and why?
2. What are the most common side effects I should watch for based on my specific situation?
3. How will you monitor me for serious side effects, and how often?
4. What should I do if I experience side effects between appointments?
5. Are there any pre-existing conditions I have that might increase my risk for certain side effects?
6. What supportive medications or treatments do you have available if I develop side effects?
7. If I develop a serious side effect, would you pause treatment, stop it, or adjust the dose?

The Balance

While immunotherapy side effects can be significant, they're often manageable with proper monitoring and treatment. Many patients tolerate immunotherapy well, and for endometrial cancer—especially advanced cases—the benefits often outweigh the risks. According to NCCN Guidelines, immunotherapy has shown meaningful improvements in survival for patients with advanced or recurrent endometrial cancer.

Your healthcare team will work with you to maximize benefits while minimizing harm through careful monitoring and proactive management of any side effects that develop.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.